未经证实:连续血糖监测(CGM)系统越来越多地用作接受胰岛素治疗的患者自我血糖监测(SMBG)的替代或辅助手段。然而,关于间歇性扫描CGM或闪现CGM(isCGM)作用的现有证据仍然有限.该共识旨在评估西班牙专家对isCGM在血糖变异性评估中的作用的一致程度。降低糖化血红蛋白(HbA1c)水平,胰岛素治疗的选择和调整。
UNASSIGNED:德尔菲方法用于在两轮调查中达成共识。共有431名西班牙内分泌学家参加了关于isCGM的34项问卷调查的第一轮,427名参加了第二轮。在第2轮中解决了任何分歧。
联合国:达成了32项声明的共识,在第二轮之后,SMBG最终商定了四项。有一个高度的共识,即isCGM有助于评估血糖变异性,改善HbA1c水平,并能指导1型糖尿病患者的治疗变化。然而,对于常规使用四分位距评估血糖变异性或选择HbA1c作为监测血糖控制的主要参数,目前尚无共识.
UNASSIGNED:大多数西班牙专家认为isCGM系统适用于:(1)识别血糖变异性并促进其管理,(2)评估高血糖作为HbA1c水平的补充,(3)指导胰岛素选择和给药的治疗决策。isCGM系统是患者和医疗保健专业人员改善胰岛素依赖型糖尿病患者血糖控制的有用工具。
Continuous glucose monitoring (CGM) systems are increasingly being adopted as an alternative or adjunct to self-monitoring of blood glucose (SMBG) by patients receiving insulin therapy. However, the available evidence on the role of intermittently scanned CGM or flash CGM (isCGM) remains limited. This
consensus aims to evaluate the degree of agreement among Spanish experts on the role of isCGM in the evaluation of glycemic variability, reduction of glycosylated hemoglobin (HbA1c) levels, and selection and adjustment of insulin therapy.
Delphi methodology was used to achieve
consensus in two survey rounds. A total of 431 Spanish endocrinologists participated in the first round of a 34-item questionnaire survey on isCGM and 427 participated in the second round. Any disagreement was resolved in round 2.
Consensus was reached for 32 statements, and four items were ultimately agreed upon SMBG after round 2. There was a high degree of
consensus that isCGM helps to evaluate glycemic variability, improves HbA1c levels, and can guide therapeutic changes in type 1 diabetes patients. However, there was no
consensus on the routine use of the interquartile range to evaluate glycemic variability or the selection of HbA1c as the main parameter for monitoring glycemic control.
Most Spanish experts believe that the isCGM system is appropriate for: (1) identifying glycemic variability and facilitating its management, (2) evaluating hyperglycemia as a complement of HbA1c levels, and (3) guiding therapeutic decisions on insulin selection and dosing. The isCGM system is a useful tool for patients and health care professionals to improve glycemic control in insulin-dependent diabetes.